Mark Robert Tobin
Director, Innovation Pharmaceuticals Inc.
Companies
- LIGHTBRIDGE CorpBoard member Oct 4, 2021 to now1
- Innovation Pharmaceuticals Inc.Board member Jul 7, 2016 to Jul 7, 20162
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- LIGHTBRIDGE Corp LTBR66,669 shares3$350.3K at $5.25Aug 11, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 11, 2026Sold 15,000 shares at $8.99 of LIGHTBRIDGE Corp3
- Aug 6, 2026Granted 10,000 shares of LIGHTBRIDGE Corp4
- Jan 2, 2026Granted 10,631 shares of LIGHTBRIDGE Corp5
- Sep 2, 2025Sold 3,000 shares at $14.21 of LIGHTBRIDGE Corp6
- Aug 28, 2025Granted 2,000 shares of LIGHTBRIDGE Corp7
- Aug 28, 2025Granted 3,000 shares of LIGHTBRIDGE Corp7
- Aug 28, 2025Granted 5,000 shares of LIGHTBRIDGE Corp7
- Aug 28, 2025Granted 5,000 shares of LIGHTBRIDGE Corp7
- Aug 28, 2025Granted 5,000 shares of LIGHTBRIDGE Corp7
- Jun 2, 2025Sold 3,000 shares at $15.42 of LIGHTBRIDGE Corp8
- Mar 12, 2025Granted 11,588 shares of LIGHTBRIDGE Corp9
- Dec 4, 2024Granted 17,183 shares of LIGHTBRIDGE Corp10
- Nov 20, 2024Sold 4,000 shares at $6.47 of LIGHTBRIDGE Corp11
- Nov 20, 2023Granted 10,076 shares of LIGHTBRIDGE Corp12
- Jan 3, 2023Granted 10,417 shares of LIGHTBRIDGE Corp13
- Mar 28, 2022Sold 1,500 shares at $8.94 of LIGHTBRIDGE Corp14
- Nov 18, 2021Granted 3,274 shares of LIGHTBRIDGE Corp15
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARLIGHTBRIDGE Corp, Board member
- 2
- 3
- 4SEC EDGARForm 4 filed Aug 7, 2026
- 5SEC EDGARForm 4 filed Jan 5, 2026
- 6SEC EDGARForm 4 filed Sep 3, 2025
- 7SEC EDGARForm 4 filed Aug 29, 2025
- 8SEC EDGARForm 4 filed Jun 4, 2025
- 9SEC EDGARForm 4 filed Mar 14, 2025
- 10SEC EDGARForm 4 filed Dec 6, 2024
- 11SEC EDGARForm 4 filed Nov 22, 2024
- 12SEC EDGARForm 4 filed Nov 22, 2023
- 13SEC EDGARForm 4 filed Jan 5, 2023
- 14SEC EDGARForm 4 filed Mar 29, 2022
- 15SEC EDGARForm 4 filed Nov 22, 2021